共 50 条
- [1] A Phase II, randomized, double-blind, placebo-controlled, dose-finding study of survodutide (BI 456906) in people living with overweight/obesity [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 153
- [4] Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial [J]. LANCET, 2021, 398 (10317): : 2160 - 2172
- [8] Dose-finding study of linaclotide in Japanese patients with chronic constipation: A phase II randomized, double-blind, and placebo-controlled study [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 30 (12):